The plan includes a target to advance five adeno-associated virus (AAV)-based gene therapy candidates into the pivotal stage or commercial ...
https://www.google.com/url?rct=j&sa=t&url=https://seekingalpha.com/news/3808610-rgnx-stock-gains-on-the-launch-of-5x25-strategy&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHBjmTt4mIqn16lHLknRO_NuMx_kg
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.